Notable Call Buying Activity Continues in Celgene (CELG) Following Reported Acquisition of Juno Therapeutics (JUNO) -Susquehanna

Susquehanna options strategist Alison Edwards notes call buying activity in Celgene (NASDAQ: CELG), as an investor bought 3k Mar 110 Calls for $2.85, adding to Feb call buying yesterday, following CELG's reported acquisition of Juno Therapeutics (NASDAQ: JUNO) for $87 per share.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 4 calls to 1 put with a focus on September 165 calls into quarter results
• lululemon athletica (LULU) call put ratio 1 call to 1 put into quarter results
• Planet Labs (PL) call put ratio 2.1 calls to 1 put into quarter results